the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Market Research Report

Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Published by Global Markets Direct Contact us : +1-860-674-8796
Published 2009/01 Content info Pages: 101
Product code LABD80205
Price From  US $ 3000 Order/Price list
US $ 3000 PDF by E-mail (Single User License)
US $ 6000 PDF By E-mail (Site license)
US $ 9000 PDF By E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of the Markets Covered in the Report 12
3.1 Neurology Devices 12
3.2 CSF (Cerebro Spinal Fluid) Management 12
3.2.1 Hydrocephalus shunt 12
3.2.2 Intra Cranial Pressure (ICP) Monitors 12
3.3 Interventional Neurology 12
3.3.1 Aneurysm Clips 12
3.3.2 Embolic System 12
3.3.3 Navigational System 13
3.4 Neurostimulation Device 13
3.4.1 Spinal Cord Stimulator (SCS) 13
3.4.2 Deep Brain Stimulator (DBS) 13
3.4.3 Vagus Nerve stimulation (VNS) 13
3.5 Neurosurgical Products (Neuroendoscopes) 14
3.5.1 Neuroendoscopes 14
3.6 Radio surgery 14
3.6.1 Cyber Knife Radiosurgery 14
3.6.2 Gamma Knife Radiosurgery 14
4 Healthcare Sector Review 15
5 Regulation System 16
5.1 Approval Process 16
5.2 Registration Procedures 17
5.3 Registration of Class I, Class IIa and Class IIb devices at DPPC 17
5.4 Declaration of Conformity (Self certification) 18
5.5 Free Sale Certificate 18
5.6 CE Certificate 19
6 Pricing and Reimbursement 20
7 Distribution Structure 21
8 Neurology Devices In Egypt 22
8.1 Neurology Devices Cross Country Comparison (2000-2012) 22
8.2 Neurology Devices, Egypt, Overall Revenues ($ mn), 2000-2012 23
8.3 Neurology Devices, Egypt, Category Volume (Units), 2000-2012 27
8.4 Neurology Devices, Egypt Company share (2006-2007) 29
9 CSF Management In Egypt 30
9.1 CSF Management Overall Revenue (2000-2012) 30
9.2 CSF Management Overall Volume (2000-2012) 32
9.3 CSF Management Average Price (2000-2012) 34
9.4 CSF Management Distribution Share (2006-2007) 35
9.5 CSF Management, Egypt, Company Share (2006-2007) 36
10 Interventional Neurology In Egypt 37
10.1 Interventional Neurology Overall Revenue (2000-2012) 37
10.1.1 Embolic Systems Overall Revenues (2000-2012) 39
10.1.2 Navigational Systems Overall Revenues (2000-2012) 41
10.2 Interventional Neurology Overall Volume (2000-2012) 43
10.2.1 Embolic Systems Overall Volume (2000-2012) 45
10.2.2 Navigational Systems Overall Volume (2000-2012) 47
10.3 Interventional Neurology Average Price (2000-2012) 49
10.4 Interventional Neurology Distribution Share (2006-2007) 50
10.5 Interventional Neurology, Egypt, Company Share (2006-2007) 51
11 Neurostimulation Devices In Egypt 52
11.1 Neurostimulation Devices Overall Revenue (2000-2012) 52
11.2 Neurostimulation Devices Overall Volume (2000-2012) 54
11.3 Neurostimulation Devices Average Price (2000-2012) 56
11.4 Neurostimulation Devices Distribution Share (2006-2007) 57
11.5 Neurostimulation Devices, Egypt, Company Share (2006-2007) 58
12 Neurosurgical Products (Neuroendoscopes)In Egypt 59
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 59
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 61
12.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 63
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 64
12.5 Neurosurgical Products (Neuroendoscopes), Egypt, Company Share (2006-2007) 65
13 Medtronic, Inc. Company Profile 66
13.1 Company Overview 66
13.2 Value Chain Analysis 66
13.2.1 Manufacturing 67
13.2.2 Product Development 67
13.2.3 Sales and Marketing 67
13.3 Medtronic, Inc. Pipeline Products 68
13.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 68
13.3.2 Medtronic, Inc. Pipeline Products by Development Stage 70
13.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 72
13.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 74
13.3.5 Medtronic, Inc. Pipeline Products by News Summary 75
14 Codman & Shurtleff, Inc. Company Profile 76
14.1 Company Overview 76
15 Boston Scientific Corporation Company Profile 77
15.1 Company Overview 77
15.2 Value Chain Analysis 77
15.2.1 Manufacturing 78
15.2.2 Product Development 78
15.2.3 Sales and Marketing 79
15.3 Boston Scientific Corporation Pipeline Products 80
15.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type 80
15.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 81
15.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 82
15.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 83
15.3.5 Boston Scientific Corporation Pipeline Products by News Summary 84
16 B. Braun Melsungen AG Company Profile 86
16.1 Company Overview 86
16.2 Value Chain Analysis 86
16.2.1 Manufacturing 87
16.2.2 Product Development 87
16.2.3 Sales and Marketing 88
16.2.4 B. Braun Melsungen AG Pipeline Products by Equipment Type 89
16.2.5 B. Braun Melsungen AG Pipeline Products by Development Stage 89
16.2.6 B. Braun Melsungen AG Pipeline Products by Therapy Area 89
16.2.7 B. Braun Melsungen AG Pipeline Products by Clinical Trials 90
16.2.8 B. Braun Melsungen AG Pipeline Products by News Summary 90
17 Cyberonics, Inc. Company Profile 91
17.1 Company Overview 91
17.1.1 Cyberonics, Inc. Pipeline Products by Equipment Type 92
17.1.2 Cyberonics, Inc. Pipeline Products by Development Stage 92
17.1.3 Cyberonics, Inc. Pipeline Products by Therapy Area 92
18 Cordis Corporation Company Profile 93
18.1 Company Overview 93
18.2 Cordis Corporation Pipeline Products 94
18.2.1 Cordis Corporation Pipeline Products by Equipment Type 94
18.2.2 Cordis Corporation Pipeline Products by Development Stage 94
18.2.3 Cordis Corporation Pipeline Products by Therapy Area 95
18.2.4 Cordis Corporation Pipeline Products by Clinical Trials 95
18.2.5 Cordis Corporation Pipeline Products by News Summary 95
19 Appendix 96
19.1 Global Markets Direct Research Methodology 96
19.2 Coverage 97
19.3 Secondary Research 97
19.4 Primary Research 98
19.5 Models 98
19.6 Forecasts 99
19.7 Expert Panels 99
19.8 Currency Conversion 100
19.9 Contact Us 101
19.10 Disclaimer 101

1.1 List of Tables
Table 1: Neurology Devices Cross Country Comparison (2000-2012) 22
Table 2: Neurology Devices, Egypt, Overall Revenues ($ mn), 2000-2012 23
Table 3: Neurology Devices, Egypt, Portfolio Analysis, 2000-2012 24
Table 4: Neurology Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 25
Table 5: Neurology Devices, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 26
Table 6: Neurology Devices, Egypt, Category Volume (Units), 2000-2012 27
Table 7: Neurology Devices, Egypt, Category Volume (Units), Historic, 2000-2007 28
Table 8: Neurology Devices, Egypt, Category Volume (Units), Forecast, 2007-2012 28
Table 9: Neurology Devices, Egypt Company share by Revenue ($ mn), 2006-2007 29
Table 10: CSF Management, Egypt, Revenue ($ mn), Historic, 2000-2007 30
Table 11: CSF Management, Egypt, Revenue ($ mn), Forecast, 2007-2012 31
Table 12: CSF Management, Egypt, Overall Volume (Units), Historic, 2000-2007 32
Table 13: CSF Management, Egypt, Overall Volume (Units), Forecast, 2007-2012 33
Table 14: CSF Management, Egypt, Average Price ($), Historic, 2000-2007 34
Table 15: CSF Management, Egypt, Average Price ($), Forecast, 2007-2012 34
Table 16: CSF Management, Egypt, Distribution Share by Revenue ($mn), 2006-2007 35
Table 17: CSF Management, Egypt, Company Share by Revenue ($ mn), 2006-2007 36
Table 18: Interventional Neurology, Egypt, Revenue ($ mn), Historic, 2000-2007 37
Table 19: Interventional Neurology, Egypt, Revenue ($ mn), Forecast, 2007-2012 38
Table 20: Embolic Systems, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 39
Table 21: Embolic Systems, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Table 22: Navigational Systems, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 41
Table 23: Navigational Systems, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Table 24: Interventional Neurology, Egypt, Overall Volume (Units), Historic, 2000-2007 43
Table 25: Interventional Neurology, Egypt, Overall Volume (Units), Forecast, 2007-2012 44
Table 26: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 45
Table 27: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 46
Table 28: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 47
Table 29: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 48
Table 30: Interventional Neurology, Egypt, Average Price ($), Historic, 2000-2007 49
Table 31: Interventional Neurology, Egypt, Average Price ($), Forecast, 2007-2012 49
Table 32: Interventional Neurology, Egypt, Distribution Share by Revenue ($mn), 2006-2007 50
Table 33: Interventional Neurology, Egypt, Company Share by Revenue ($ mn), 2006-2007 51
Table 34: Neurostimulation Devices, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 52
Table 35: Neurostimulation Devices, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 53
Table 36: Neurostimulation Devices, Egypt, Overall Volume (Units), Historic, 2000-2007 54
Table 37: Neurostimulation Devices, Egypt, Overall Volume (Units), Forecast, 2007-2012 55
Table 38: Neurostimulation Devices, Egypt, Average Price ($), Historic, 2000-2007 56
Table 39: Neurostimulation Devices, Egypt, Average Price ($), Forecast, 2007-2012 56
Table 40: Neurostimulation Devices, Egypt, Distribution Share by Revenue ($mn), 2006-2007 57
Table 41: Neurostimulation Devices, Egypt, Company Share by Revenue ($ mn), 2006-2007 58
Table 42: Neurosurgical Products (Neuroendoscopes), Egypt, Revenue ($ mn), Historic, 2000-2007 59
Table 43: Neurosurgical Products (Neuroendoscopes), Egypt, Revenue ($ mn), Forecast, 2007-2012 60
Table 44: Neurosurgical Products (Neuroendoscopes), Egypt, Overall Volume (Units), Historic, 2000-2007 61
Table 45: Neurosurgical Products (Neuroendoscopes), Egypt, Overall Volume (Units), Forecast, 2007-2012 62
Table 46: Neurosurgical Products (Neuroendoscopes), Egypt, Average Price ($), Historic, 2000-2007 63
Table 47: Neurosurgical Products (Neuroendoscopes), Egypt, Average Price ($), Forecast, 2007-2012 63
Table 48: Neurosurgical Products (Neuroendoscopes), Egypt, Distribution Share by Revenue ($mn), 2006-2007 64
Table 49: Neurosurgical Products (Neuroendoscopes), Egypt, Company Share by Revenue ($ mn), 2006-2007 65
Table 50: Medtronic, Inc. Pipeline Products by Equipment Type 68
Table 51: Medtronic, Inc. Pipeline Products By Development Stage 70
Table 52: Medtronic, Inc. Pipeline Products By Therapy Area 72
Table 53: Medtronic, Inc. Pipeline Products By Clinical Trials 74
Table 54: Medtronic, Inc. Pipeline Products By News Summaries 75
Table 55: Boston Scientific Corporation Pipeline Products by Equipment Type 80
Table 56: Boston Scientific Corporation Pipeline Products By Development Stage 81
Table 57: Boston Scientific Corporation Pipeline Products By Therapy Area 82
Table 58: Boston Scientific Corporation Pipeline Products By Clinical Trials 83
Table 59: Boston Scientific Corporation Pipeline Products By News Summaries 84
Table 60: B. Braun Melsungen AG Pipeline Products by Equipment Type 89
Table 61: B. Braun Melsungen AG Pipeline Products By Development Stage 89
Table 62: B. Braun Melsungen AG Pipeline Products By Therapy Area 89
Table 63: B. Braun Melsungen AG Pipeline Products By Clinical Trials 90
Table 64: B. Braun Melsungen AG Pipeline Products By News Summaries 90
Table 65: Cyberonics, Inc. Pipeline Products by Equipment Type 92
Table 66: Cyberonics, Inc. Pipeline Products By Development Stage 92
Table 67: Cyberonics, Inc. Pipeline Products By Therapy Area 92
Table 68: Cordis Corporation Pipeline Products by Equipment Type 94
Table 69: Cordis Corporation Pipeline Products By Development Stage 94
Table 70: Cordis Corporation Pipeline Products By Therapy Area 95
Table 71: Cordis Corporation Pipeline Products By Clinical Trials 95
Table 72: Cordis Corporation Pipeline Products By News Summaries 95
Table 73: Currency Conversion from USD to Local Currency at 2007 Constant Rate 100

1.2 List of Figures
Figure 1: Neurology Devices Cross Country Comparison (2000-2012) 22
Figure 2: Neurology Devices, Egypt, Overall Revenues ($ mn), 2000-2012 23
Figure 3: Neurology Devices, Egypt, Portfolio Analysis, 2000-2012 24
Figure 4: Neurology Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 25
Figure 5: Neurology Devices, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 26
Figure 6: Neurology Devices, Egypt Company share (%), 2007 29
Figure 7: CSF Management, Egypt, Revenue ($ mn), Historic, 2000-2007 30
Figure 8: CSF Management, Egypt, Revenue ($ mn), Forecast, 2007-2012 31
Figure 9: CSF Management, Egypt, Overall Volume (Units), Historic, 2000-2007 32
Figure 10: CSF Management, Egypt, Overall Volume (Units), Forecast, 2007-2012 33
Figure 11: CSF Management, Egypt, Company Share (%), 2007 36
Figure 12: Interventional Neurology, Egypt, Revenue ($ mn), Historic, 2000-2007 37
Figure 13: Interventional Neurology, Egypt, Revenue ($ mn), Forecast, 2007-2012 38
Figure 14: Embolic Systems, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 39
Figure 15: Embolic Systems, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Figure 16: Navigational Systems, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 41
Figure 17: Navigational Systems, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Figure 18: Interventional Neurology, Egypt, Overall Volume (Units), Historic, 2000-2007 43
Figure 19: Interventional Neurology, Egypt, Overall Volume (Units), Forecast, 2007-2012 44
Figure 20: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 45
Figure 21: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 46
Figure 22: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 47
Figure 23: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 48
Figure 24: Interventional Neurology, Egypt, Company Share (%), 2007 51
Figure 25: Neurostimulation Devices, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 52
Figure 26: Neurostimulation Devices, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 53
Figure 27: Neurostimulation Devices, Egypt, Overall Volume (Units), Historic, 2000-2007 54
Figure 28: Neurostimulation Devices, Egypt, Overall Volume (Units), Forecast, 2007-2012 55
Figure 29: Neurostimulation Devices, Egypt, Company Share (%), 2007 58
Figure 30: Neurosurgical Products (Neuroendoscopes), Egypt, Revenue ($ mn), Historic, 2000-2007 59
Figure 31: Neurosurgical Products (Neuroendoscopes), Egypt, Revenue ($ mn), Forecast, 2007-2012 60
Figure 32: Neurosurgical Products (Neuroendoscopes), Egypt, Overall Volume (Units), Historic, 2000-2007 61
Figure 33: Neurosurgical Products (Neuroendoscopes), Egypt, Overall Volume (Units), Forecast, 2007-2012 62
Figure 34: Neurosurgical Products (Neuroendoscopes), Egypt, Company Share (%), 2007 65
Figure 35: Medtronic, Inc. Value Chain Analysis 66
Figure 36: Boston Scientific Corporation Value Chain Analysis 77
Figure 37: B. Braun Melsungen AG Value Chain Analysis 86
Figure 38: Global Markets Direct Methodology 96

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.